References
- Genga KR, Russell JA. Update of sepsis in the intensive care unit. J Innate Immun. 2017;9(5):441–455.
- Perner A, Gordon AC, De Backer D, et al. Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med. 2016;42(12):1958–1969.
- Fink MP, Warren HS. Strategies to improve drug development for sepsis. Nat Rev Drug Discov. 2014;13(10):741–758.
- Opal SM, Laterre PF, Francois B, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154–1162.
- Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–2064.
- Rice TW, Wheeler AP, Bernard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685–1694.
- Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174.
- Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–1316.
- Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.
- Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129(3):290–295.
- Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care. 2017;7(1):117.
- Frantzeskaki F, Armaganidis A, Orfanos SE. Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation. Respiration. 2017;93(3):212–225.
- Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.
- Yipp BG, Kubes P. NETosis: how vital is it? Blood. 2013;122(16):2784–2794.
- Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–1535.
- Andrades ME, Ritter C, Dal-Pizzol F. The role of free radicals in sepsis development. Front Biosci (Elite Ed). 2009;1:277–287.
- Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med. 2007;42(2):153–164.
- Huet O, Dupic L, Harrois A, et al. Oxidative stress and endothelial dysfunction during sepsis. Front Biosci (Landmark Ed). 2011;16:1986–1995.
- Koide T, Foster D, Yoshitake S, et al. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry. 1986;25(8):2220–2225.
- Poon IK, Patel KK, Davis DS, et al. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood. 2011;117(7):2093–2101.
- Borza DB, Tatum FM, Morgan WT. Domain structure and conformation of histidine-proline-rich glycoprotein. Biochemistry. 1996;35(6):1925–1934.
- Leung LL. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest. 1986;77(4):1305–1311.
- Lijnen HR, Hoylaerts M, Collen D. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. J Biol Chem. 1983;258(6):3803–3808.
- Peterson CB, Morgan WT, Blackburn MN. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding. J Biol Chem. 1987;262(16):7567–7574.
- Silverstein RL, Leung LL, Harpel PC, et al. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest. 1985;75(6):2065–2073.
- Bosshart H, Heinzelmann M. Endotoxin-neutralizing effects of histidine-rich peptides. FEBS Lett. 2003;553(1–2):135–140.
- Poon IK, Hulett MD, Parish CR. Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcgammaRI on phagocytes. Blood. 2010;115(12):2473–2482.
- Tugues S, Roche F, Noguer O, et al. Histidine-rich glycoprotein uptake and turnover is mediated by mononuclear phagocytes. PLoS One. 2014;9(9):e107483.
- Zhong H, Wake H, Liu K, et al. Effects of histidine-rich glycoprotein on erythrocyte aggregation and hemolysis: implications for a role under septic conditions. J Pharmacol Sci. 2018;136(3):97–106.
- Morgan WT. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. Biochemistry. 1985;24(6):1496–1501.
- Priebatsch KM, Poon IK, Patel KK, et al. Divalent metal binding by histidine-rich glycoprotein differentially regulates higher order oligomerisation and proteolytic processing. FEBS Lett. 2017;591(1):164–176.
- Wake H, Mori S, Liu K, et al. Histidine-rich glycoprotein prevents septic lethality through regulation of immunothrombosis and inflammation. EBioMedicine. 2016;9:180–194.
- Kuroda K, Wake H, Mori S, et al. Decrease in histidine-rich glycoprotein as a novel biomarker to predict sepsis among systemic inflammatory response syndrome. Crit Care Med. 2018;46(4):570–576.
- Mori S, Takahashi HK, Yamaoka K, et al. High affinity binding of serum histidine-rich glycoprotein to nickel-nitrilotriacetic acid: the application to microquantification. Life Sci. 2003;73(1):93–102.
- Valko M, Jomova K, Rhodes CJ, et al. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol. 2016;90(1):1–37.
- Zuo L, Zhou T, Pannell BK, et al. Biological and physiological role of reactive oxygen species–the good, the bad, and the ugly. Acta Physiol (Oxf). 2015;214(3):329–348.
- Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126–1167.
- Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721–1741.
- Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24–38.
- Martins AC, Almeida JI, Lima IS, et al. Iron metabolism and the inflammatory response. IUBMB Life. 2017;69(6):442–450.
- Sill C, Biehl R, Hoffmann B, et al. Structure and domain dynamics of human lactoferrin in solution and the influence of Fe(III)-ion ligand binding. BMC Biophys. 2016;9:7.
- Takami T, Sakaida I. Iron regulation by hepatocytes and free radicals. J Clin Biochem Nutr. 2011;48(2):103–106.
- Lv H, Shang P. The significance, trafficking and determination of labile iron in cytosol, mitochondria and lysosomes. Metallomics. 2018;10(7):899–916.
- Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–2093.
- Wake H. Histidine-rich glycoprotein modulates the blood-vascular system in septic condition. Acta Med Okayama. 2019;73(5):379–382.